Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut

Eastern Connecticut Hematology and Oncology Associates is a clinical research site located in Norwich, Connecticut, United States 06360.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Eastern Connecticut Hematology and Oncology Associates has participated in 103 clinical trials with 32 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Norwich

Browse all research sites in Connecticut · View every site in Norwich

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Eastern Connecticut Hematology and Oncology Associates?

Eastern Connecticut Hematology and Oncology Associates has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Eastern Connecticut Hematology and Oncology Associates conducted?

Eastern Connecticut Hematology and Oncology Associates has 103 clinical trials on record, with 32 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Eastern Connecticut Hematology and Oncology Associates accredited by Crixeo Clinical Trials?

Eastern Connecticut Hematology and Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Eastern Connecticut Hematology and Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.